Monday, August 31, 2026

FuboTV Stock Impressive Jump 10% So Far On Friday, Outperforms Market

FuboTV Stock  Impressive Jump 10%  So Far On Friday, Outperforms Market

FuboTV (NYSE: FUBO) witnessed a significant surge of 10.82% to $.72 on Wednesday, after experiencing two sessions of losses. This rise coincided with an upswing on New York Stock Exchange's market index that rose 0.53% to $356.64. This signaled an encouraging trading session.

FuboTV's Profile

FuboTV Inc. of New York is well known for their live TV streaming platform that caters to a range of interests - encompassing sports, news and entertainment content - across an international scope. Their digital television service can be utilized via streaming devices like smartTVs or computers or via mobile phones and tablets for accessing this digital television service.

FuboTV's Financials

FuboTV reported an Earnings Per Share (EPS) figure of 1.95 during its latest financial reporting cycle, providing insight into their earnings power as well as providing an indication of its valuation.

Market Expectations of FuboTV

FuboTV's growth predictions are optimistic; analysts anticipate a 52.4% quarterly expansion and 56.1% year-on-year. It appears the market expects revenues for FuboTV to increase significantly, fuelling optimism among investors and contributing to its stock price appreciation. Analysts and investors may take comfort from such estimates that further boost the company's value.

More news about FuboTV (FUBO).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com